Disease-A-Month
Volume 55, Issue 7 , Pages 419-421 , July 2009

Introduction

References 

  1. Fauci AS. Infectious diseases: Considerations for the 21st century. Clin Infect Dis. 2001;32:675–685
  2. Trends in causes of death among the elderly. Aging Trends No. 1, March 2001. Publication of the Centers for Disease Control and Prevention. Atlanta, GA. National Center for Health Statistics.
  3. Klevens RM, Edwards JR, Richards CL. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Pub Health Rep. 2007;122:160–166March-April
  4. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) Report (Data summary for 2006, issued 2007). Am J Infect Cont. 2007;35:290–301
  5. Association for Professionals in Infection Control and epidemiology (APIC)Government advocacy. http://www.apic.org/content/navigationmenu/governmentadvocacy/mandatoryreporting/abouttheissue/about_the_issue.htm
  6. Tokars JI, Richards C, Andrus M, et al. The changing face of surveillance for health care associated infections. Clin Infect Dis. 2004;39:1347–1352
  7. American Hospital Association, Hospital Statistics 2004. Chicago Health Forum LLC; 2005;
  8. Burke JP. Infection control—A problem for patient safety. N Engl J Med. 2004;348:651–656
  9. Carey AJ, Saiman L, Polin RA. Hospital Acquired Infections in the NICU: Epidemiology for the new millennium. Clin Perinatol. 2008;35:223–249
  10. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Cont. 2004;32:470–485
  11. Nguyen QV. Hospital Acquired Infections, 2007; August http://www.emedicine.com/ped/fulltopic/topic1619.htm.
  12. McFee RB. Avian influenza: The next pandemic?. Dis Mon. 2007;53(7):337–388
  13. Wenzel RP, Edmond MB. Team based prevention of catheter related infections. N Engl J Med. 2006;355(26):2781–2783
  14. Summary of notifiable diseases—United States, 2002 (MMWR). Morb Mortal Wkly Rep. 2004;51(53):1–84
  15. Deaths: Leading causes for 2001. Natl Vital Stat Rep. 2003;52(9):Table E
  16. Scheurer DB, Hicks LS, Cook EF, et al. Short report—Accuracy of ICD-9 coding for Clostridium difficile infections: A retrospective cohort. Epidemiol Infect. 2007;135:1010–1013
  17. Kyne L. Health care associated costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346–353
  18. Goldmann DA. Epidemiology and prevention of pediatric viral respiratory infections in health care institutions. Emerg Infect Dis. 2001;7:249–253
  19. Population Reference Bureau. United States Government. NCHS–FASTATS–Leading Causes of Death Deaths–Leading Causes. (Data are for US for year indicated). Number of deaths for leading causes of death http://www.cdc.gov/nchs/fastats/lcod.htm.
  20. O'Connor J. C diff—Rise in UK deaths (72% increase between 2005 and 2006). Feb 28, 2008 http://patient-health-education.suite101.com/article.cfm/c_difficile_rise_in_uk_deathsLast accessed 6/24/08
  21. Deaths involving MRSA and Clostridium difficile continue to rise. Health statistics Quarterly. Spring 2007. 22 Feb2007. Issued by the Office of National Statistics, London SW1V 2QQ. http://www.statistics.gov.uk/releases.
  22. Fordtran JS. Colitis due to Clostridium difficile toxins: Underdiagnosed, highly virulent, and nosocomial. Proc Bayl Univ Med Cent. 2006;19:3–12
  23. Dramatic rise in C diff deaths (BBC News February 28 2008). http://news.bbc.co.uk/1/hi/health/7268578.stmLast accessed 8/12/08
  24. Sunenshine RH, McDonald LC. Clostridium difficile-associated disease: New challenges from an established pathogen. Cleve Clin J Med. 2006;73(2):187–197
  25. Friedenberg FK. Clostridium difficile associated disease: Changing epidemiology and treatment options (Medscape Gastroenterology). http://www.medscape.com/viewarticle/563386_printLast accessed 6/25/08
  26. Ashu NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors and molecular epidemiology of antibiotic associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol. 2006;44:2785–2791
  27. Kuijper EJ, Coignard TP. Emergence of Clostridium difficile associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl 6):2–18
  28. McDonald LC, Kilgore GE, Thomson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–2441
  29. Jarvis WR. Infection Control and Changing Health Care Delivery Systems. Emerg Infect Dis. 2001;7(2):170–173
  30. Halsey J. Current and future treatment modalities for Clostridium difficile associated disease. Am J Health Syst Pharm. 2008;65:705–715
  31. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. 2001;7(2):337–341
  32. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile associated diarrhea. Clin Infect Dis. 2005;41:1254–1260
  33. Guideline for hand hygiene in Health Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force (A report of the CDC). MMWR Morb Mortal Wkly Rep. 2002;51:RR-16
  34. Best practices document for the management of Clostridium difficile in all health care settings. Provincial Infectious Diseases Advisory Committee (PIDAC). Ministry of Health and Long Term Care. Published December 2004, Revised November 2007.

PII: S0011-5029(09)00046-7

doi: 10.1016/j.disamonth.2009.03.013

Disease-A-Month
Volume 55, Issue 7 , Pages 419-421 , July 2009

Article Tools